Vexim

About:

Vexim is specializes in the development and sale of vertebral compression fracture (VCF) solutions.

Website: https://fr.vexim.com

Twitter/X: VeximSA

Description:

VEXIM specializes in the development and sale of vertebral compression fracture (VCF) solutions. The company's flagship product is the SpineJack® system, a mechanical expandable VCF implant for fracture reduction and stabilization. The VEXIM portfolio is highly complementary to the Interventional Spine (IVS) business of Stryker's Instruments division whose key products include an extensive and innovative portfolio for vertebral augmentation, vertebroplasty, and radiofrequency ablation procedures, along with a diagnostic tool and decompression treatment advances for contained disc herniations. Vexim was created in February 2006 and is headquartered in Balma, France.

Total Funding Amount:

$17.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Balma, Midi-Pyrenees, France

Founded Date:

2006-02-01

Founders:

Alain Leonard

Number of Employees:

101-250

Last Funding Date:

2015-01-28

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai